WellSpan Oncology Research — York, Pennsylvania

WellSpan Oncology Research is a clinical research site located in York, Pennsylvania, United States 17403.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

WellSpan Oncology Research has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Lennox Gastaut Syndrome (LGS).

Sponsors: Pfizer, Hoffmann-La Roche, Takeda.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for WellSpan Oncology Research?

WellSpan Oncology Research has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has WellSpan Oncology Research conducted?

WellSpan Oncology Research has 4 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Lennox Gastaut Syndrome (LGS).

Is WellSpan Oncology Research accredited by Crixeo Health?

WellSpan Oncology Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about WellSpan Oncology Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.